EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

An observational study investigating soluble immune checkpoints as indicators of severe COVID-19

Ricarda Cortés-Vieyra iD, Sergio Gutiérrez-Castellanos, Anel Gómez-García, Alejandro Bravo-Patiño iD, Fernando Calderón-Rico iD, José Daniel Martínez-Sepúlveda, Roberto Ortega-Flores, Francisco Perez-Duran iD, Luis Enrique Franco-Correa iD, Alicia Gabriela Zamora-Avilés iD, Rosa Elvira Nuñez-Anita iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.03776-23 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Ricarda Cortés-Vieyra und 10 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina Veterinaria y Zootecnia (FMVZ), Universidad Michoacana de San Nicolás de San Nicolás de Hidalgo (UMSNH), Morelia-Zinapécuaro, Me…. Hauptthemen laut MEDLINE: COVID-19, Biomarkers, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología (CONACYT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate the immunomodulatory behavior of soluble immune checkpoints (sICPs) and other biomarkers in the pathophysiology of SARS-CoV-2 infection. The study included 59 adult participants, 43 of whom tested positive for SARS-CoV-2. Patients were divided into three cohorts: those with moderate disease ( n = 16), recovered patients with severe disease ( n = 13), and deceased patients with severe disease ( n = 16). In addition, 16 participants were pre-pandemic subjects negative for SARS-CoV-2. The relative activity of neutralizing antibodies (rNAbs) against SARS-CoV-2 and the values of 14 sICPs in peripheral blood were compared between the four groups. Because the increase of markers values of inflammation [NLR > 12; CRP > 150 mg/L] and venous thromboembolism [D-dimer > 0.5 mg/L] has been associated with mortality from COVID-19, the total and differential leukocyte counts, the NLR, and CRP and D-dimer values were obtained in patients with severe disease. No differences in rNAbs were observed between the cohorts. Only the levels of five sICPs, sCD27, sHVEM sTIM-3, sPD-1, and sPDL-1, were significantly higher in patients with severe rather than moderate disease. The sPDL-2 level and NLR were higher in deceased patients than in recovered patients. However, there was no difference in CRP and D-dimer values between the two groups. Of the five soluble biomarkers compared among patients with severe disease, only sPDL-2 was higher in deceased patients than in recovered patients. This suggests that immuno-inhibitory sICPs might be used as indicators for severe COVID-19, with sPDL-2 used to assess individual risk for fatality. IMPORTANCE COVID-19, the disease caused by a SARS-CoV-2 infection, generates a broad spectrum of clinical symptoms, progressing to multiorgan failure in the most severe cases. As activation of the immune system is pivotal to eradicating the virus, future research should focus on identifying reliable biomarkers to efficiently predict the outcome in severe COVID-19 cases. Soluble immune checkpoints represent the function of the immune system and are easily determined in peripheral blood. This research could lead to implementing more effective severity biomarkers for COVID-19, which could increase patients’ survival rate and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19BiomarkersSARS-CoV-2HumansMaleFemaleMiddle AgedAgedAdultSeverity of Illness IndexAntibodies, NeutralizingImmune Checkpoint ProteinsFibrin Fibrinogen Degradation ProductsAged, 80 and over

Stichwörter der Autor:innen

COVID-19SARS-CoV-2immune checkpointsobservational study

Substanzen

BiomarkersAntibodies, NeutralizingImmune Checkpoint ProteinsFibrin Fibrinogen Degradation Productsfibrin fragment D

Autor:innen und Institutionen

  • Facultad de Medicina Veterinaria y Zootecnia (FMVZ), Universidad Michoacana de San Nicolás de San Nicolás de Hidalgo (UMSNH), Morelia-Zinapécuaro, Mexico.
  • Centro de Investigación Biomédica de Michoacán, División de Investigación Clínica, Instituto Mexicano del Seguro Social, Morelia, Mexico.
  • Centro Multidisciplinario de Estudios en Biotecnología de la FMVZ, UMSNH, Morelia-Zinapécuaro, Mexico.
  • Instituto de investigaciones Químico Biológicas, UMSNH, Morelia, México.

ORCID-Profile: Ricarda Cortés-Vieyra, Alejandro Bravo-Patiño, Fernando Calderón-Rico, Francisco Perez-Duran, Luis Enrique Franco-Correa, Alicia Gabriela Zamora-Avilés, Rosa Elvira Nuñez-Anita

Förderung

  • Consejo Nacional de Ciencia y Tecnología (CONACYT)

Zitieren

APA

Cortés-Vieyra, R., Gutiérrez-Castellanos, S., Gómez-García, A., Bravo-Patiño, A., Calderón-Rico, F., Martínez-Sepúlveda, J. D., Ortega-Flores, R., Perez-Duran, F., Franco-Correa, L. E., Zamora-Avilés, A. G., & Nuñez-Anita, R. E. (2024). An observational study investigating soluble immune checkpoints as indicators of severe COVID-19. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03776-23

Vancouver

Cortés-Vieyra R, Gutiérrez-Castellanos S, Gómez-García A, Bravo-Patiño A, Calderón-Rico F, Martínez-Sepúlveda JD, et al. An observational study investigating soluble immune checkpoints as indicators of severe COVID-19. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03776-23

BibTeX
@article{CortsVieyra2024,
  author = {Cortés-Vieyra, Ricarda and Gutiérrez-Castellanos, Sergio and Gómez-García, Anel and Bravo-Patiño, Alejandro and Calderón-Rico, Fernando and Martínez-Sepúlveda, José Daniel and Ortega-Flores, Roberto and Perez-Duran, Francisco and Franco-Correa, Luis Enrique and Zamora-Avilés, Alicia Gabriela and Nuñez-Anita, Rosa Elvira},
  title = {An observational study investigating soluble immune checkpoints as indicators of severe COVID-19},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.03776-23}
}
Kostenlos starten →